Healthcare -
Biotechnology - NASDAQ - US
$ 0.214
5.52 %
$ 14 M
Market Cap
-0.14
P/E
LYRA - CAPITAL EXPENDITURES
Capital Expenditures LYRA - Lyra Therapeutics, Inc.
-1.05 M
LAST VALUE
44.38%
2 YEAR CAGR
-95.14%
5 YEAR CAGR
0.00%
10 YEAR CAGR